Microencapsulated potassium chloride 15 MEQ Extended Release Oral Tablet [Klor-Con]
RxNorm concept 832731, branded drug (sbd). Prescribable name: Klor-Con M15 15 MEQ Extended Release Oral Tablet.
- RxCUI
- 832731
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/832731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Klor-Con M15 1125 MG Microencapsulated Extended Release Oral Tablet; Klor-Con M15 15 MEQ Microencapsulated Extended Release Oral Tablet; Microencapsulated K+ Chloride 15 MEQ Extended Release Oral Tablet [Klor-Con]; Microencapsulated Klor-Con 15 MEQ Extended Release Oral Tablet; Microencapsulated Pot Chloride 15 MEQ Extended Release Oral Tablet [Klor-Con]
Related concepts
- potassium chloride 15 MEQ (SCDC, consists of)
- potassium chloride 15 MEQ [Klor-Con] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Klor-Con (BN, has ingredient)
- Microencapsulated potassium chloride 15 MEQ Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00245531801
- 00245531811
- 00245531889
- 66758018001
- 66758018006
- 66758018013
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 832731 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/832731 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 832731. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.